Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Biometrics
|
January 15, 2010
Simplified Bayesian sensitivity analysis for mismeasured and unobserved confounders
P Gustafson, L C McCandless, A R Levy, et al.
Statistics in Medicine
|
September 12, 2007
Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research
K M Johnston, P Gustafson, A R Levy, et al.
Scandinavian Journal of Medicine & Science in Sports
|
January 23, 2008
Adherence to sport injury rehabilitation programs: an integrated psycho-social approach
A R Levy, R C J Polman, P J Clough
American Heart Journal
|
August 30, 2001
Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada
A R Levy, A H Briggs, C Demers, et al.
Journal of the American Geriatrics Society
|
March 17, 1999
Survival after percutaneous endoscopic gastrostomy among older residents of Quebec
D N Fisman, A R Levy, D R Gifford, et al.
Current Medical Research and Opinion
|
March 5, 2014
The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes
S Lane, A R Levy, J Mukherjee, et al.
Epidemiology (Cambridge, Mass.)
|
March 21, 1998
Inclement weather and the risk of hip fracture
A R Levy, D R Bensimon, N E Mayo, et al.
Alimentary Pharmacology & Therapeutics
|
January 22, 2003
Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding
R A Enns, Y M Gagnon, K P Rioux, et al.
The Journal of Sports Medicine and Physical Fitness
|
February 11, 2015
Sources of sport confidence, imagery type and performance among competitive athletes: the mediating role of sports confidence
A R Levy, J Perry, A R Nicholls, et al.
Current Oncology (Toronto, Ont.)
|
February 14, 2014
Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes
A R Levy, D Zou, N Risebrough, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Biometrics
|
January 15, 2010
Simplified Bayesian sensitivity analysis for mismeasured and unobserved confounders
P Gustafson, L C McCandless, A R Levy, et al.
Statistics in Medicine
|
September 12, 2007
Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research
K M Johnston, P Gustafson, A R Levy, et al.
Scandinavian Journal of Medicine & Science in Sports
|
January 23, 2008
Adherence to sport injury rehabilitation programs: an integrated psycho-social approach
A R Levy, R C J Polman, P J Clough
American Heart Journal
|
August 30, 2001
Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada
A R Levy, A H Briggs, C Demers, et al.
Journal of the American Geriatrics Society
|
March 17, 1999
Survival after percutaneous endoscopic gastrostomy among older residents of Quebec
D N Fisman, A R Levy, D R Gifford, et al.
Current Medical Research and Opinion
|
March 5, 2014
The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes
S Lane, A R Levy, J Mukherjee, et al.
Epidemiology (Cambridge, Mass.)
|
March 21, 1998
Inclement weather and the risk of hip fracture
A R Levy, D R Bensimon, N E Mayo, et al.
Alimentary Pharmacology & Therapeutics
|
January 22, 2003
Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding
R A Enns, Y M Gagnon, K P Rioux, et al.
The Journal of Sports Medicine and Physical Fitness
|
February 11, 2015
Sources of sport confidence, imagery type and performance among competitive athletes: the mediating role of sports confidence
A R Levy, J Perry, A R Nicholls, et al.
Current Oncology (Toronto, Ont.)
|
February 14, 2014
Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes
A R Levy, D Zou, N Risebrough, et al.
Page
of 4